rank,protein_id,score,known_target,associated_adverse_effects,reasoning
1,RET - ret proto-oncogene (human),1.0,True,,"Path 1: Pralsetinib --[inhibits]--> RET - ret proto-oncogene (human) (evidence: 0.3 nM (IC50 (AID: 1934929). Path 2: No (RET - ret proto-oncogene (human), associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
2,Proto-oncogene tyrosine-protein kinase receptor Ret (human),1.0,True,,"Path 1: Pralsetinib --[inhibits]--> Proto-oncogene tyrosine-protein kinase receptor Ret (human) (evidence: 0.4 nM (IC50 (AID: 2091116). Path 2: No (Proto-oncogene tyrosine-protein kinase receptor Ret (human), associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
3,CCDC6 - coiled-coil domain containing 6 (human),1.0,True,"Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adrenal Cortex Diseases | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenocortical Carcinoma | Anemia | Anemia, Aplastic | Anemia, Hemolytic | Anemia, Hemolytic, Autoimmune | Anemia, Hypochromic | Anemia, Iron-Deficiency | Anemia, Macrocytic | Anemia, Megaloblastic | Anemia, Sickle Cell | Anemia, Sideroblastic | Anus Neoplasms | Arrhythmias, Cardiac | Autoimmune Diseases | Basal Cell Carcinoma | Bone Marrow Neoplasms | Bone Neoplasms | Brain Neoplasms | Breast Neoplasms | Bronchial Neoplasms | Burkitt Lymphoma | Carcinoid Tumor | Carcinoma | Carcinoma in Situ | Carcinoma, Adenosquamous | Carcinoma, Bronchogenic | Carcinoma, Ductal, Breast | Carcinoma, Ehrlich Tumor | Carcinoma, Embryonal | Carcinoma, Endometrioid | Carcinoma, Hepatocellular | Carcinoma, Large Cell | Carcinoma, Lewis Lung | Carcinoma, Merkel Cell | Carcinoma, Non-Small-Cell Lung | Carcinoma, Ovarian Epithelial | Carcinoma, Pancreatic Ductal | Carcinoma, Papillary | Carcinoma, Renal Cell | Carcinoma, Signet Ring Cell | Carcinoma, Small Cell | Carcinoma, Squamous Cell | Carcinoma, Transitional Cell | Cardiac Conduction System Disease | Cardiac Output, High | Cardiac Output, Low | Cardio-Renal Syndrome | Cardiovascular Abnormalities | Cardiovascular Diseases | Central Nervous System Neoplasms | Cerebrovascular Disorders | Cholangiocarcinoma | Cholestasis, Intrahepatic | Choriocarcinoma | Clear-cell metastatic renal cell carcinoma | Colonic Neoplasms | Colorectal Neoplasms | Congenital Hypothyroidism | Conotruncal cardiac defects | Death, Sudden, Cardiac | Dementia, Vascular | Desmoid Tumors | Desmoplastic Small Round Cell Tumor | Diabetes Mellitus, Congenital Autoimmune | Disseminated Intravascular Coagulation | Edema, Cardiac | Encephalomyelitis, Autoimmune, Experimental | Endometrial Neoplasms | Esophageal Neoplasms | Esophageal Squamous Cell Carcinoma | Euthyroid Sick Syndromes | Fallopian Tube Neoplasms | Familial primary gastric lymphoma | Gallbladder Neoplasms | Gastrointestinal Neoplasms | Genital Neoplasms, Female | Glycosuria, Renal | Granulosa cell tumor of the ovary | Head and Neck Neoplasms | Hematologic Neoplasms | Hepatic Encephalopathy | Hepatic Insufficiency | Hepatic Veno-Occlusive Disease | Hepatorenal Syndrome | Hypertension | Hypertension, Malignant | Hypertension, Portal | Hypertension, Pregnancy-Induced | Hypertension, Pulmonary | Hypertension, Renal | Hypertension, Renovascular | Hyperthyroidism | Hypomagnesemia 2, renal | Hypopharyngeal Neoplasms | Hypothyroidism | Hypothyroidism, Autoimmune | IMMUNE SUPPRESSION | Immune Complex Diseases | Immune System Diseases | Inflammatory Breast Neoplasms | Intestinal Neoplasms | Intracranial Hypertension | Kidney Neoplasms | Laryngeal Neoplasms | Leukemia | Leukemia L1210 | Leukemia, Erythroblastic, Acute | Leukemia, Experimental | Leukemia, Lymphocytic, Chronic, B-Cell | Leukemia, Lymphoid | Leukemia, Monocytic, Acute | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Leukemia, Plasma Cell | Leukemia, Prolymphocytic, T-Cell | Leukemia, Promyelocytic, Acute | Leukemia, Radiation-Induced | Leukemia, T-Cell | Leukemia-Lymphoma, Adult T-Cell | Leydig Cell Tumor | Liver Neoplasms | Liver Neoplasms, Experimental | Lung Diseases | Lung Diseases, Interstitial | Lung Diseases, Obstructive | Lung Injury | Lung Neoplasms | Lung agenesis | Lymphatic Metastasis | Lymphoma | Lymphoma, AIDS-Related | Lymphoma, B-Cell | Lymphoma, Extranodal NK-T-Cell | Lymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-Cell | Lymphoma, Non-Hodgkin | Lymphoma, Primary Effusion | Lymphoma, T-Cell | Lymphoma, T-Cell, Cutaneous | Male Germ Cell Tumor | Mammary Neoplasms, Animal | Mammary Neoplasms, Experimental | Massive Hepatic Necrosis | Maxillary Sinus Neoplasms | Mouth Neoplasms | Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Neoplasm Invasiveness | Neoplasm Metastasis | Neoplasm Recurrence, Local | Neoplasms | Neoplasms, Bone Tissue | Neoplasms, Experimental | Neoplasms, Germ Cell and Embryonal | Neoplasms, Glandular and Epithelial | Neoplasms, Mesothelial | Neovascularization, Pathologic | Neuroectodermal Tumors | Neuroectodermal Tumors, Primitive | Neuroectodermal Tumors, Primitive, Peripheral | Neutropenia | Nonseminomatous germ cell tumor | Nose Neoplasms | Ocular Hypertension | Ovarian Neoplasms | Pancreatic Neoplasms | Pancreatic cancer, adult | Paraganglioma, Extra-Adrenal | Paraquat lung | Peripheral Vascular Diseases | Pharyngeal Neoplasms | Phyllodes Tumor | Pituitary Neoplasms | Pleural Neoplasms | Porphyrias, Hepatic | Precancerous Conditions | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Prostatic Neoplasms | Pseudolymphoma | Pseudotumor Cerebri | Pulmonary Arterial Hypertension | Rectal Neoplasms | Renal Artery Obstruction | Renal Insufficiency | Renal Insufficiency, Chronic | Renal hypouricemia | Salivary Gland Neoplasms | Sigmoid Neoplasms | Skin Neoplasms | Small Cell Lung Carcinoma | Soft Tissue Neoplasms | Splenic Neoplasms | Squamous Cell Carcinoma of Head and Neck | Stomach Neoplasms | Testicular Germ Cell Tumor | Testicular Neoplasms | Thyroid Cancer, Papillary | Thyroid Diseases | Thyroid Dysgenesis | Thyroid Hormone Metabolism, Abnormal | Thyroid Neoplasms | Thyroid cancer, follicular | Tongue Neoplasms | Tracheal Neoplasms | Triple Negative Breast Neoplasms | Tumor Lysis Syndrome | Ureteral Neoplasms | Urethral Neoplasms | Urinary Bladder Neoplasms | Urogenital Neoplasms | Urologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Uveal Neoplasms | Vaginal Neoplasms | Vascular Calcification | Vascular Diseases | Vascular Malformations | Vascular Remodeling | Vascular System Injuries | Wilms Tumor","Path 1: Pralsetinib --[inhibits]--> CCDC6 - coiled-coil domain containing 6 (human) (evidence: 0.4 nM (IC50 (AID: 1895760). Path 2: CCDC6 - coiled-coil domain containing 6 (human) --[associated_with]--> Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adrenal Cortex Diseases | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenocortical Carcinoma | Anemia | Anemia, Aplastic ... (+222 more)."
4,PTK2B,1.0,True,,"Path 1: Pralsetinib --[inhibits]--> PTK2B (evidence: Active nan (PTK2B). Path 2: No (PTK2B, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
5,RET,1.0,True,,"Path 1: Pralsetinib --[inhibits]--> RET (evidence: Active nan (Proto-oncogene c-Ret (RET). Path 2: No (RET, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
6,HRAS,1.0,False,,"Path 1: No (Pralsetinib, inhibits, HRAS) edge in KG; GNN predicts link (score=1.0000). Path 2: No (HRAS, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
7,CCDC6,1.0,True,,"Path 1: Pralsetinib --[inhibits]--> CCDC6 (evidence: Active nan (CCDC6). Path 2: No (CCDC6, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
8,KDR,1.0,True,,"Path 1: Pralsetinib --[inhibits]--> KDR (evidence: Active nan (kinase insert domain receptor). Path 2: No (KDR, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
9,KIF5B,1.0,True,,"Path 1: Pralsetinib --[inhibits]--> KIF5B (evidence: Active nan (KIF5B). Path 2: No (KIF5B, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
10,EML4,1.0,False,,"Path 1: No (Pralsetinib, inhibits, EML4) edge in KG; GNN predicts link (score=1.0000). Path 2: No (EML4, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
11,DRD2,1.0,True,,"Path 1: Pralsetinib --[inhibits]--> DRD2 (evidence: Active nan (DRD2). Path 2: No (DRD2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
12,KIF5B - kinesin family member 5B (human),1.0,True,"Abdominal Neoplasms | Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adenocarcinoma, Papillary | Adrenal Cortex Diseases | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenal Insufficiency | Adrenocortical Carcinoma | Anemia | Anemia, Aplastic | Anemia, Hemolytic | Anemia, Hemolytic, Autoimmune | Anemia, Hypochromic | Anemia, Iron-Deficiency | Anemia, Macrocytic | Anemia, Megaloblastic | Anemia, Sickle Cell | Anemia, Sideroblastic | Anus Neoplasms | Arrhythmias, Cardiac | Autoimmune Diseases | Basal Cell Carcinoma | Bone Marrow Neoplasms | Bone Neoplasms | Brain Neoplasms | Breast Neoplasms | Breast Neoplasms, Male | Burkitt Lymphoma | Carcinoid Tumor | Carcinoma | Carcinoma in Situ | Carcinoma, Ductal | Carcinoma, Ductal, Breast | Carcinoma, Ehrlich Tumor | Carcinoma, Embryonal | Carcinoma, Endometrioid | Carcinoma, Hepatocellular | Carcinoma, Lewis Lung | Carcinoma, Merkel Cell | Carcinoma, Non-Small-Cell Lung | Carcinoma, Ovarian Epithelial | Carcinoma, Renal Cell | Carcinoma, Squamous Cell | Carcinoma, Transitional Cell | Cardiac Conduction System Disease | Cardiac Output, High | Cardiac Output, Low | Cardio-Renal Syndrome | Cardiovascular Abnormalities | Cardiovascular Diseases | Central Nervous System Neoplasms | Cerebrovascular Disorders | Cholangiocarcinoma | Cholestasis, Intrahepatic | Cholestasis, progressive familial intrahepatic 3 | Choriocarcinoma | Choroidal Neovascularization | Colonic Neoplasms | Colorectal Neoplasms | Congenital Hypothyroidism | Conotruncal cardiac defects | Death, Sudden, Cardiac | Dementia, Vascular | Desmoid Tumors | Desmoplastic Small Round Cell Tumor | Disseminated Intravascular Coagulation | Ear Neoplasms | Edema, Cardiac | Encephalomyelitis, Autoimmune, Experimental | Endometrial Neoplasms | Esophageal Neoplasms | Esophageal Squamous Cell Carcinoma | Euthyroid Sick Syndromes | Familial primary gastric lymphoma | Fanconi Anemia | Gallbladder Neoplasms | Gastrointestinal Neoplasms | Genital Neoplasms, Female | Genital Neoplasms, Male | Granulosa cell tumor of the ovary | Head and Neck Neoplasms | Hematologic Neoplasms | Hepatic Encephalopathy | Hepatic Insufficiency | Hepatic Veno-Occlusive Disease | Hypertension | Hypertension, Malignant | Hypertension, Portal | Hypertension, Pregnancy-Induced | Hypertension, Pulmonary | Hypertension, Renal | Hypertension, Renovascular | Hyperthyroidism | Hypothyroidism | IMMUNE SUPPRESSION | Immune Complex Diseases | Immune System Diseases | Inflammatory Breast Neoplasms | Intestinal Neoplasms | Intracranial Hypertension | Kidney Neoplasms | Laryngeal Neoplasms | Leukemia | Leukemia L1210 | Leukemia, Erythroblastic, Acute | Leukemia, Experimental | Leukemia, Lymphoid | Leukemia, Monocytic, Acute | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Leukemia, Promyelocytic, Acute | Leukemia, T-Cell | Leukemia-Lymphoma, Adult T-Cell | Leydig Cell Tumor | Liver Neoplasms | Liver Neoplasms, Experimental | Lung Diseases | Lung Diseases, Interstitial | Lung Diseases, Obstructive | Lung Injury | Lung Neoplasms | Lung agenesis | Lymphatic Metastasis | Lymphoma | Lymphoma, AIDS-Related | Lymphoma, B-Cell | Lymphoma, Extranodal NK-T-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Lymphoma, T-Cell | Mammary Neoplasms, Animal | Mammary Neoplasms, Experimental | Massive Hepatic Necrosis | Maxillary Sinus Neoplasms | Mixed Tumor, Mullerian | Mouth Neoplasms | Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Neoplasm Invasiveness | Neoplasm Metastasis | Neoplasm Micrometastasis | Neoplasm Recurrence, Local | Neoplasms | Neoplasms, Bone Tissue | Neoplasms, Experimental | Neoplasms, Glandular and Epithelial | Neoplasms, Hormone-Dependent | Neoplasms, Mesothelial | Neoplasms, Radiation-Induced | Neovascularization, Pathologic | Nerve Sheath Neoplasms | Neuroectodermal Tumors, Primitive, Peripheral | Neutropenia | Nose Neoplasms | Ocular Hypertension | Ovarian Neoplasms | Pancreatic Neoplasms | Pancreatic cancer, adult | Paraganglioma, Extra-Adrenal | Peripheral Vascular Diseases | Pharyngeal Neoplasms | Phyllodes Tumor | Pituitary Neoplasms | Pleural Neoplasms | Porphyrias, Hepatic | Precancerous Conditions | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Prostatic Neoplasms | Pseudolymphoma | Pseudotumor Cerebri | Pulmonary Arterial Hypertension | Rectal Neoplasms | Renal Insufficiency | Renal Insufficiency, Chronic | Renal hypouricemia | Retinal Neovascularization | Salivary Gland Neoplasms | Sebaceous Gland Neoplasms | Skin Diseases, Vascular | Skin Neoplasms | Small Cell Lung Carcinoma | Soft Tissue Neoplasms | Splenic Neoplasms | Squamous Cell Carcinoma of Head and Neck | Stomach Neoplasms | Testicular Germ Cell Tumor | Testicular Neoplasms | Thyroid Diseases | Thyroid Hormone Metabolism, Abnormal | Thyroid Neoplasms | Thyroid cancer, follicular | Thyroid cancer, medullary | Tongue Neoplasms | Triple Negative Breast Neoplasms | Tumor Lysis Syndrome | Ureteral Neoplasms | Urinary Bladder Neoplasms | Urogenital Neoplasms | Urologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Uveal Neoplasms | Vascular Calcification | Vascular Diseases | Vascular Malformations | Vascular Remodeling | Vascular System Injuries | Wilms Tumor","Path 1: Pralsetinib --[inhibits]--> KIF5B - kinesin family member 5B (human) (evidence: 4.0 nM (GI50 (AID: 1704858). Path 2: KIF5B - kinesin family member 5B (human) --[associated_with]--> Abdominal Neoplasms | Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adenocarcinoma, Papillary | Adrenal Cortex Diseases | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenal Insufficiency ... (+204 more)."
13,Tyrosine-protein kinase JAK2 (human),1.0,True,"Acidosis, Renal Tubular | Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adenocarcinoma, Clear Cell | Adenocarcinoma, Mucinous | Adrenal Cortex Diseases | Adrenal Cortex Neoplasms | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenal Hyperplasia, Congenital | Adrenal Insufficiency | Adrenocortical Carcinoma | Anemia | Anemia, Aplastic | Anemia, Hemolytic | Anemia, Hemolytic, Autoimmune | Anemia, Hypochromic | Anemia, Iron-Deficiency | Anemia, Macrocytic | Anemia, Megaloblastic | Anemia, Refractory, with Excess of Blasts | Anemia, Sickle Cell | Anemia, Sideroblastic | Anus Neoplasms | Arrhythmias, Cardiac | Autoimmune Diseases | Basal Cell Carcinoma | Basal Ganglia Cerebrovascular Disease | Bone Marrow Neoplasms | Bone Neoplasms | Brachydactyly with hypertension | Brain Neoplasms | Breast Neoplasms | Breast Neoplasms, Male | Bronchial Neoplasms | Burkitt Lymphoma | Carcinoid Tumor | Carcinoma | Carcinoma in Situ | Carcinoma, Adenosquamous | Carcinoma, Bronchogenic | Carcinoma, Ductal | Carcinoma, Ductal, Breast | Carcinoma, Ehrlich Tumor | Carcinoma, Embryonal | Carcinoma, Endometrioid | Carcinoma, Hepatocellular | Carcinoma, Islet Cell | Carcinoma, Large Cell | Carcinoma, Lewis Lung | Carcinoma, Lobular | Carcinoma, Merkel Cell | Carcinoma, Non-Small-Cell Lung | Carcinoma, Ovarian Epithelial | Carcinoma, Pancreatic Ductal | Carcinoma, Papillary | Carcinoma, Renal Cell | Carcinoma, Small Cell | Carcinoma, Squamous Cell | Carcinoma, Transitional Cell | Cardiac Complexes, Premature | Cardiac Conduction System Disease | Cardiac Output, High | Cardiac Output, Low | Cardiac Tamponade | Cardiovascular Abnormalities | Cardiovascular Diseases | Central Nervous System Neoplasms | Cerebrovascular Disorders | Cholangiocarcinoma | Cholestasis, Extrahepatic | Cholestasis, Intrahepatic | Cholestasis, progressive familial intrahepatic 3 | Choriocarcinoma | Choroidal Neovascularization | Clear-cell metastatic renal cell carcinoma | Colitis-Associated Neoplasms | Colonic Neoplasms | Colorectal Neoplasms | Congenital Hypothyroidism | Conotruncal cardiac defects | Corneal Neovascularization | Cystadenocarcinoma | Death, Sudden, Cardiac | Dementia, Vascular | Desmoid Tumors | Desmoplastic Small Round Cell Tumor | Disseminated Intravascular Coagulation | Edema, Cardiac | Encephalomyelitis, Autoimmune, Experimental | Endocrine Gland Neoplasms | Endometrial Neoplasms | Esophageal Neoplasms | Esophageal Squamous Cell Carcinoma | Essential Hypertension | Euthyroid Sick Syndromes | Fallopian Tube Neoplasms | Familial primary gastric lymphoma | Fanconi Anemia | Gallbladder Neoplasms | Gastrointestinal Neoplasms | Gastrointestinal Stromal Tumors | Genital Neoplasms, Female | Genital Neoplasms, Male | Giant Cell Tumor of Bone | Glycosuria, Renal | Granulosa cell tumor of the ovary | Head and Neck Neoplasms | Hematologic Neoplasms | Hepatic Encephalopathy | Hepatic Insufficiency | Hepatic Veno-Occlusive Disease | Hepatitis, Autoimmune | Hypertension | Hypertension, Malignant | Hypertension, Portal | Hypertension, Pregnancy-Induced | Hypertension, Pulmonary | Hypertension, Renal | Hypertension, Renovascular | Hyperthyroidism | Hypomagnesemia 2, renal | Hypothyroidism | IMMUNE SUPPRESSION | Idiopathic intracranial hypertension with papilledema | Immune Complex Diseases | Immune System Diseases | Inflammatory Breast Neoplasms | Intestinal Neoplasms | Intracranial Hypertension | Kidney Neoplasms | Laryngeal Neoplasms | Leukemia | Leukemia L1210 | Leukemia, Erythroblastic, Acute | Leukemia, Experimental | Leukemia, Large Granular Lymphocytic | Leukemia, Lymphocytic, Chronic, B-Cell | Leukemia, Lymphoid | Leukemia, Monocytic, Acute | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Acute | Leukemia, Myelomonocytic, Chronic | Leukemia, Plasma Cell | Leukemia, Promyelocytic, Acute | Leukemia, T-Cell | Leukemia-Lymphoma, Adult T-Cell | Leydig Cell Tumor | Liver Neoplasms | Liver Neoplasms, Experimental | Lung Diseases | Lung Diseases, Interstitial | Lung Diseases, Obstructive | Lung Diseases, Parasitic | Lung Injury | Lung Neoplasms | Lung agenesis | Lymphatic Metastasis | Lymphoma | Lymphoma, AIDS-Related | Lymphoma, B-Cell | Lymphoma, Extranodal NK-T-Cell | Lymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-Cell | Lymphoma, Non-Hodgkin | Lymphoma, T-Cell | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | Male Germ Cell Tumor | Mammary Neoplasms, Animal | Mammary Neoplasms, Experimental | Massive Hepatic Necrosis | Maxillary Sinus Neoplasms | Meningeal Carcinomatosis | Mesenteric Vascular Occlusion | Mixed Tumor, Mullerian | Mouth Neoplasms | Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Neoplasm Invasiveness | Neoplasm Metastasis | Neoplasm Micrometastasis | Neoplasm Recurrence, Local | Neoplasms | Neoplasms, Bone Tissue | Neoplasms, Experimental | Neoplasms, Fibrous Tissue | Neoplasms, Germ Cell and Embryonal | Neoplasms, Glandular and Epithelial | Neoplasms, Hormone-Dependent | Neoplasms, Radiation-Induced | Neoplasms, Second Primary | Neoplasms, Squamous Cell | Neoplasms, Unknown Primary | Neovascularization, Pathologic | Nervous System Neoplasms | Neuritis, Autoimmune, Experimental | Neuroectodermal Tumors | Neuroectodermal Tumors, Primitive | Neuroectodermal Tumors, Primitive, Peripheral | Neuroendocrine Tumors | Neutropenia | Nonseminomatous germ cell tumor | Nose Neoplasms | Ocular Hypertension | Ovarian Neoplasms | Pancreatic Neoplasms | Pancreatic cancer, adult | Paraganglioma, Extra-Adrenal | Peripheral Vascular Diseases | Pharyngeal Neoplasms | Phyllodes Tumor | Pituitary Neoplasms | Pleural Neoplasms | Porphyrias, Hepatic | Precancerous Conditions | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Pregnancy Complications, Cardiovascular | Prostatic Neoplasms | Pseudolymphoma | Pseudotumor Cerebri | Pulmonary Arterial Hypertension | Rectal Neoplasms | Renal Aminoacidurias | Renal Artery Obstruction | Renal Insufficiency | Renal Insufficiency, Chronic | Renal hypouricemia | Retinal Neovascularization | Salivary Gland Neoplasms | Sebaceous Gland Neoplasms | Sinus Arrest, Cardiac | Skin Diseases, Vascular | Skin Neoplasms | Small Cell Lung Carcinoma | Soft Tissue Neoplasms | Splenic Neoplasms | Squamous Cell Carcinoma of Head and Neck | Stomach Neoplasms | Testicular Germ Cell Tumor | Testicular Neoplasms | Thyroid Cancer, Papillary | Thyroid Diseases | Thyroid Dysgenesis | Thyroid Hormone Metabolism, Abnormal | Thyroid Neoplasms | Thyroid cancer, follicular | Thyroid cancer, medullary | Tongue Neoplasms | Tracheal Neoplasms | Triple Negative Breast Neoplasms | Tumor Lysis Syndrome | Ureteral Neoplasms | Urethral Neoplasms | Urinary Bladder Neoplasms | Urogenital Neoplasms | Urologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Uveal Neoplasms | Vaginal Neoplasms | Vascular Calcification | Vascular Diseases | Vascular Headaches | Vascular Malformations | Vascular Neoplasms | Vascular Remodeling | Vascular System Injuries | Vulvar Neoplasms | Wilms Tumor","Path 1: Pralsetinib --[inhibits]--> Tyrosine-protein kinase JAK2 (human) (evidence: 2.0 nM (IC50 (AID: 1776972). Path 2: Tyrosine-protein kinase JAK2 (human) --[associated_with]--> Acidosis, Renal Tubular | Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adenocarcinoma, Clear Cell | Adenocarcinoma, Mucinous | Adrenal Cortex Diseases | Adrenal Cortex Neoplasms | Adrenal Gland Diseases ... (+267 more)."
14,FLT3 - fms related receptor tyrosine kinase 3 (human),1.0,True,"Acidosis, Renal Tubular | Acute Lung Injury | Acute erythroleukemia | Adenocarcinoma | Adenocarcinoma of Lung | Adrenal Cortex Diseases | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenal Hyperplasia, Congenital | Adrenal Insufficiency | Adrenocortical Carcinoma | Anemia | Anemia, Aplastic | Anemia, Hemolytic | Anemia, Hemolytic, Autoimmune | Anemia, Hypochromic | Anemia, Iron-Deficiency | Anemia, Refractory, with Excess of Blasts | Anemia, Sideroblastic | Anus Neoplasms | Arrhythmias, Cardiac | Autoimmune Diseases | Bone Marrow Neoplasms | Brain Neoplasms | Brain Stem Neoplasms | Breast Neoplasms | Bronchial Neoplasms | Burkitt Lymphoma | Carcinoma | Carcinoma in Situ | Carcinoma, Bronchogenic | Carcinoma, Ductal, Breast | Carcinoma, Ehrlich Tumor | Carcinoma, Embryonal | Carcinoma, Endometrioid | Carcinoma, Hepatocellular | Carcinoma, Large Cell | Carcinoma, Lewis Lung | Carcinoma, Merkel Cell | Carcinoma, Non-Small-Cell Lung | Carcinoma, Ovarian Epithelial | Carcinoma, Pancreatic Ductal | Carcinoma, Papillary | Carcinoma, Renal Cell | Carcinoma, Small Cell | Carcinoma, Squamous Cell | Carcinoma, Transitional Cell | Cardiac Complexes, Premature | Cardiac Conduction System Disease | Cardiac Output, High | Cardiac Tamponade | Cardiovascular Abnormalities | Cardiovascular Diseases | Central Nervous System Neoplasms | Cerebrovascular Disorders | Cholangiocarcinoma | Cholestasis, Intrahepatic | Choriocarcinoma | Colonic Neoplasms | Colorectal Neoplasms | Congenital Hypothyroidism | Death, Sudden, Cardiac | Dementia, Vascular | Desmoid Tumors | Disseminated Intravascular Coagulation | Edema, Cardiac | Encephalomyelitis, Autoimmune, Experimental | Endometrial Neoplasms | Esophageal Neoplasms | Esophageal Squamous Cell Carcinoma | Euthyroid Sick Syndromes | Fallopian Tube Neoplasms | Gallbladder Neoplasms | Gastrointestinal Neoplasms | Gastrointestinal Stromal Tumors | Genital Neoplasms, Female | Glycosuria, Renal | Granulosa cell tumor of the ovary | Head and Neck Neoplasms | Hematologic Neoplasms | Hepatic Encephalopathy | Hepatic Insufficiency | Hepatic Veno-Occlusive Disease | Hepatitis, Autoimmune | Hypertension | Hypertension, Portal | Hypertension, Pregnancy-Induced | Hypertension, Pulmonary | Hypertension, Renovascular | Hyperthyroidism | Hypomagnesemia 2, renal | Hypothyroidism | Immune Complex Diseases | Immune System Diseases | Inflammatory Breast Neoplasms | Intestinal Neoplasms | Intracranial Hypertension | Kidney Neoplasms | Laryngeal Neoplasms | Leukemia | Leukemia, Experimental | Leukemia, Lymphocytic, Chronic, B-Cell | Leukemia, Lymphoid | Leukemia, Monocytic, Acute | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Leukemia, Myeloid, Chronic-Phase | Leukemia, Myelomonocytic, Chronic | Leukemia, Promyelocytic, Acute | Leukemia, T-Cell | Leukemia-Lymphoma, Adult T-Cell | Leydig Cell Tumor | Liver Neoplasms | Liver Neoplasms, Experimental | Lung Diseases | Lung Diseases, Interstitial | Lung Injury | Lung Neoplasms | Lung agenesis | Lymphatic Metastasis | Lymphoma | Lymphoma, AIDS-Related | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Large-Cell, Anaplastic | Lymphoma, Mantle-Cell | Lymphoma, Non-Hodgkin | Lymphoma, T-Cell | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | Male Germ Cell Tumor | Mammary Neoplasms, Animal | Mammary Neoplasms, Experimental | Massive Hepatic Necrosis | Maxillary Sinus Neoplasms | Mouth Neoplasms | Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Neoplasm Invasiveness | Neoplasm Metastasis | Neoplasm Recurrence, Local | Neoplasms | Neoplasms, Experimental | Neoplasms, Germ Cell and Embryonal | Neoplasms, Glandular and Epithelial | Neovascularization, Pathologic | Neuroectodermal Tumors | Neuroendocrine Tumors | Neutropenia | Nonseminomatous germ cell tumor | Nose Neoplasms | Ocular Hypertension | Ovarian Neoplasms | Pancreatic Neoplasms | Pancreatic cancer, adult | Paraganglioma, Extra-Adrenal | Peripheral Vascular Diseases | Pharyngeal Neoplasms | Pituitary Neoplasms | Pleural Neoplasms | Porphyrias, Hepatic | Precancerous Conditions | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Prostatic Neoplasms | Pseudotumor Cerebri | Rectal Neoplasms | Renal Artery Obstruction | Renal Insufficiency | Renal Insufficiency, Chronic | Salivary Gland Neoplasms | Sebaceous Gland Neoplasms | Sinus Arrest, Cardiac | Skin Neoplasms | Small Cell Lung Carcinoma | Squamous Cell Carcinoma of Head and Neck | Stomach Neoplasms | Testicular Germ Cell Tumor | Testicular Neoplasms | Thyroid Diseases | Thyroid Dysgenesis | Thyroid Hormone Metabolism, Abnormal | Thyroid Neoplasms | Thyroid cancer, follicular | Tongue Neoplasms | Tracheal Neoplasms | Triple Negative Breast Neoplasms | Ureteral Neoplasms | Urethral Neoplasms | Urinary Bladder Neoplasms | Urogenital Neoplasms | Urologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Uveal Neoplasms | Vaginal Neoplasms | Vascular Calcification | Vascular Diseases | Vascular Malformations | Vascular Remodeling | Vascular System Injuries | Wilms Tumor","Path 1: Pralsetinib --[inhibits]--> FLT3 - fms related receptor tyrosine kinase 3 (human) (evidence: 6.5 nM (IC50 (AID: 1776973). Path 2: FLT3 - fms related receptor tyrosine kinase 3 (human) --[associated_with]--> Acidosis, Renal Tubular | Acute Lung Injury | Acute erythroleukemia | Adenocarcinoma | Adenocarcinoma of Lung | Adrenal Cortex Diseases | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenal Hyperplasia, Congenital | Adrenal Insufficiency ... (+194 more)."
15,KDR - kinase insert domain receptor (human),1.0,True,"Abdominal Neoplasms | Acidosis, Renal Tubular | Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adenocarcinoma, Clear Cell | Adenocarcinoma, Mucinous | Adrenal Cortex Diseases | Adrenal Cortex Neoplasms | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenal Hyperplasia, Congenital | Adrenal Insufficiency | Adrenocortical Carcinoma | Anemia | Anemia, Aplastic | Anemia, Diamond-Blackfan | Anemia, Hemolytic | Anemia, Hemolytic, Autoimmune | Anemia, Hypochromic | Anemia, Iron-Deficiency | Anemia, Macrocytic | Anemia, Megaloblastic | Anemia, Refractory, with Excess of Blasts | Anemia, Sickle Cell | Anemia, Sideroblastic | Anus Neoplasms | Arrhythmias, Cardiac | Autoimmune Diseases | Basal Cell Carcinoma | Bone Marrow Neoplasms | Bone Neoplasms | Brachydactyly with hypertension | Brain Neoplasms | Breast Neoplasms | Breast Neoplasms, Male | Bronchial Neoplasms | Burkitt Lymphoma | Carcinoid Tumor | Carcinoma | Carcinoma in Situ | Carcinoma, Adenosquamous | Carcinoma, Bronchogenic | Carcinoma, Ductal | Carcinoma, Ductal, Breast | Carcinoma, Ehrlich Tumor | Carcinoma, Embryonal | Carcinoma, Endometrioid | Carcinoma, Hepatocellular | Carcinoma, Islet Cell | Carcinoma, Large Cell | Carcinoma, Lewis Lung | Carcinoma, Lobular | Carcinoma, Merkel Cell | Carcinoma, Non-Small-Cell Lung | Carcinoma, Ovarian Epithelial | Carcinoma, Pancreatic Ductal | Carcinoma, Papillary | Carcinoma, Renal Cell | Carcinoma, Signet Ring Cell | Carcinoma, Small Cell | Carcinoma, Squamous Cell | Carcinoma, Transitional Cell | Cardiac Complexes, Premature | Cardiac Conduction System Disease | Cardiac Output, High | Cardiac Output, Low | Cardiac Tamponade | Cardio-Renal Syndrome | Cardiovascular Abnormalities | Cardiovascular Diseases | Central Nervous System Neoplasms | Cerebellar Neoplasms | Cerebrovascular Disorders | Cholangiocarcinoma | Cholestasis, Extrahepatic | Cholestasis, Intrahepatic | Choriocarcinoma | Choroidal Neovascularization | Clear-cell metastatic renal cell carcinoma | Colonic Neoplasms | Colorectal Neoplasms | Congenital Hypothyroidism | Conotruncal cardiac defects | Corneal Neovascularization | Cystadenocarcinoma | Death, Sudden, Cardiac | Dementia, Vascular | Desmoid Tumors | Desmoplastic Small Round Cell Tumor | Diabetes Mellitus, Congenital Autoimmune | Disseminated Intravascular Coagulation | Duodenal Neoplasms | Ear Neoplasms | Edema, Cardiac | Encephalomyelitis, Autoimmune, Experimental | Endometrial Neoplasms | Esophageal Neoplasms | Esophageal Squamous Cell Carcinoma | Essential Hypertension | Euthyroid Sick Syndromes | Eye Neoplasms | Familial primary gastric lymphoma | Fanconi Anemia | Gallbladder Neoplasms | Gastro-enteropancreatic neuroendocrine tumor | Gastrointestinal Neoplasms | Gastrointestinal Stromal Tumors | Genital Neoplasms, Female | Glycosuria, Renal | Head and Neck Neoplasms | Hematologic Neoplasms | Hepatic Encephalopathy | Hepatic Insufficiency | Hepatic Veno-Occlusive Disease | Hepatitis, Autoimmune | Hepatorenal Syndrome | Hypertension | Hypertension, Malignant | Hypertension, Portal | Hypertension, Pregnancy-Induced | Hypertension, Pulmonary | Hypertension, Renal | Hypertension, Renovascular | Hyperthyroidism | Hypothyroidism | IMMUNE SUPPRESSION | Immune Complex Diseases | Immune System Diseases | Inflammatory Breast Neoplasms | Intestinal Neoplasms | Intracranial Hypertension | Kidney Neoplasms | Kidney disorder involving deposition of calcium and oxalate or phosphate in the renal tubules | Laryngeal Neoplasms | Leukemia | Leukemia L1210 | Leukemia P388 | Leukemia, Erythroblastic, Acute | Leukemia, Experimental | Leukemia, Hairy Cell | Leukemia, Lymphocytic, Chronic, B-Cell | Leukemia, Lymphoid | Leukemia, Monocytic, Acute | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | Leukemia, Myelomonocytic, Chronic | Leukemia, Myelomonocytic, Juvenile | Leukemia, Plasma Cell | Leukemia, Prolymphocytic, T-Cell | Leukemia, Promyelocytic, Acute | Leukemia, T-Cell | Leukemia-Lymphoma, Adult T-Cell | Leydig Cell Tumor | Liver Neoplasms | Liver Neoplasms, Experimental | Lung Diseases | Lung Diseases, Fungal | Lung Diseases, Interstitial | Lung Diseases, Obstructive | Lung Injury | Lung Neoplasms | Lung agenesis | Lymphatic Metastasis | Lymphoma | Lymphoma, AIDS-Related | Lymphoma, B-Cell | Lymphoma, Extranodal NK-T-Cell | Lymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Large-Cell, Anaplastic | Lymphoma, Mantle-Cell | Lymphoma, Non-Hodgkin | Lymphoma, Primary Effusion | Lymphoma, T-Cell | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | Mammary Neoplasms, Animal | Mammary Neoplasms, Experimental | Massive Hepatic Necrosis | Maxillary Sinus Neoplasms | Meningeal Carcinomatosis | Mesenteric Vascular Occlusion | Mouth Neoplasms | Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Neoplasm Invasiveness | Neoplasm Metastasis | Neoplasm Micrometastasis | Neoplasm Recurrence, Local | Neoplasms | Neoplasms, Bone Tissue | Neoplasms, Experimental | Neoplasms, Glandular and Epithelial | Neoplasms, Hormone-Dependent | Neoplasms, Mesothelial | Neoplasms, Multiple Primary | Neovascularization, Pathologic | Nervous System Neoplasms | Neuroectodermal Tumor, Melanotic | Neuroectodermal Tumors | Neuroectodermal Tumors, Primitive | Neuroectodermal Tumors, Primitive, Peripheral | Neuroendocrine Tumors | Neutropenia | Nose Neoplasms | Ocular Hypertension | Ovarian Neoplasms | Pancreatic Neoplasms | Pancreatic cancer, adult | Paraganglioma, Extra-Adrenal | Parotid Neoplasms | Peripheral Vascular Diseases | Peritoneal Neoplasms | Pharyngeal Neoplasms | Phyllodes Tumor | Pituitary Neoplasms | Pleural Neoplasms | Porphyrias, Hepatic | Precancerous Conditions | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Pregnancy Complications, Cardiovascular | Prostatic Neoplasms | Pseudolymphoma | Pseudotumor Cerebri | Pulmonary Arterial Hypertension | Rectal Neoplasms | Renal Aminoacidurias | Renal Artery Obstruction | Renal Insufficiency | Renal Insufficiency, Chronic | Renal hypouricemia | Retinal Neovascularization | Salivary Gland Neoplasms | Sebaceous Gland Neoplasms | Sigmoid Neoplasms | Sinus Arrest, Cardiac | Skin Diseases, Vascular | Skin Neoplasms | Small Cell Lung Carcinoma | Soft Tissue Neoplasms | Splenic Neoplasms | Squamous Cell Carcinoma of Head and Neck | Stomach Neoplasms | Testicular Neoplasms | Thymus Neoplasms | Thyroid Cancer, Papillary | Thyroid Diseases | Thyroid Dysgenesis | Thyroid Hormone Metabolism, Abnormal | Thyroid Neoplasms | Thyroid cancer, follicular | Thyroid cancer, medullary | Thyroiditis | Thyroiditis, Autoimmune | Tongue Neoplasms | Triple Negative Breast Neoplasms | Tumor Lysis Syndrome | Ureteral Neoplasms | Urinary Bladder Neoplasms | Urogenital Neoplasms | Urologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Uveal Neoplasms | Vaginal Neoplasms | Vascular Calcification | Vascular Diseases | Vascular Malformations | Vascular Neoplasms | Vascular Remodeling | Vascular System Injuries | Wilms Tumor","Path 1: Pralsetinib --[inhibits]--> KDR - kinase insert domain receptor (human) (evidence: 35.0 nM (IC50 (AID: 1895759). Path 2: KDR - kinase insert domain receptor (human) --[associated_with]--> Abdominal Neoplasms | Acidosis, Renal Tubular | Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adenocarcinoma, Clear Cell | Adenocarcinoma, Mucinous | Adrenal Cortex Diseases | Adrenal Cortex Neoplasms ... (+268 more)."
16,KIF11,0.9949871301651,False,,"Path 1: No (Pralsetinib, inhibits, KIF11) edge in KG; GNN predicts link (score=0.9950). Path 2: No (KIF11, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
17,HNRNPF,0.6238489151000977,False,,"Path 1: No (Pralsetinib, inhibits, HNRNPF) edge in KG; GNN predicts link (score=0.6238). Path 2: No (HNRNPF, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
18,NEK3,0.0113548068329691,False,,"Path 1: No (Pralsetinib, inhibits, NEK3) edge in KG; GNN predicts link (score=0.0114). Path 2: No (NEK3, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
19,CCNH,8.339712803717703e-05,False,,"Path 1: No (Pralsetinib, inhibits, CCNH) edge in KG; GNN predicts link (score=0.0001). Path 2: No (CCNH, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
20,LUM,2.4911291802709457e-06,False,,"Path 1: No (Pralsetinib, inhibits, LUM) edge in KG; GNN predicts link (score=0.0000). Path 2: No (LUM, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
21,PRKX,1.1216678785785918e-07,False,,"Path 1: No (Pralsetinib, inhibits, PRKX) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PRKX, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
22,BMX,6.985412248639022e-09,False,,"Path 1: No (Pralsetinib, inhibits, BMX) edge in KG; GNN predicts link (score=0.0000). Path 2: No (BMX, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
23,CLCN6,5.722001206187598e-10,False,,"Path 1: No (Pralsetinib, inhibits, CLCN6) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CLCN6, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
24,ALDH3A2,6.070842439864775e-11,False,,"Path 1: No (Pralsetinib, inhibits, ALDH3A2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ALDH3A2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
25,IRAK1,7.526386631984128e-12,False,,"Path 1: No (Pralsetinib, inhibits, IRAK1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (IRAK1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
26,SMARCA4,9.499497542753144e-13,False,,"Path 1: No (Pralsetinib, inhibits, SMARCA4) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SMARCA4, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
27,FLT3,8.319847089911793e-13,False,,"Path 1: No (Pralsetinib, inhibits, FLT3) edge in KG; GNN predicts link (score=0.0000). Path 2: No (FLT3, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
28,SMARCA2,1.3538919063551397e-13,False,,"Path 1: No (Pralsetinib, inhibits, SMARCA2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SMARCA2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
29,SCNN1B,2.402599298711224e-14,False,,"Path 1: No (Pralsetinib, inhibits, SCNN1B) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SCNN1B, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
30,FXR1,4.491067365680656e-15,False,,"Path 1: No (Pralsetinib, inhibits, FXR1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (FXR1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
31,ATP1A2,8.449740219177619e-16,False,,"Path 1: No (Pralsetinib, inhibits, ATP1A2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ATP1A2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
32,BCAM,1.5921107885788667e-16,False,,"Path 1: No (Pralsetinib, inhibits, BCAM) edge in KG; GNN predicts link (score=0.0000). Path 2: No (BCAM, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
33,KNTC1,3.0733945290244496e-17,False,,"Path 1: No (Pralsetinib, inhibits, KNTC1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (KNTC1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
34,VASP,6.153275394822235e-18,False,,"Path 1: No (Pralsetinib, inhibits, VASP) edge in KG; GNN predicts link (score=0.0000). Path 2: No (VASP, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
35,PDLIM4,1.2805845692777909e-18,False,,"Path 1: No (Pralsetinib, inhibits, PDLIM4) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PDLIM4, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
36,CSRP3,2.7683705924709667e-19,False,,"Path 1: No (Pralsetinib, inhibits, CSRP3) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CSRP3, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
37,CPT1A,6.001862258441087e-20,False,,"Path 1: No (Pralsetinib, inhibits, CPT1A) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CPT1A, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
38,IDH3A,1.3580562439603244e-20,False,,"Path 1: No (Pralsetinib, inhibits, IDH3A) edge in KG; GNN predicts link (score=0.0000). Path 2: No (IDH3A, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
39,SELENOP,2.97777346480204e-21,False,,"Path 1: No (Pralsetinib, inhibits, SELENOP) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SELENOP, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
40,NUP153,6.284374952029937e-22,False,,"Path 1: No (Pralsetinib, inhibits, NUP153) edge in KG; GNN predicts link (score=0.0000). Path 2: No (NUP153, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
41,CLK3,1.3673076159061024e-22,False,,"Path 1: No (Pralsetinib, inhibits, CLK3) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CLK3, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
42,SCT,7.140166855417734e-23,False,,"Path 1: No (Pralsetinib, inhibits, SCT) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SCT, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
43,CSF1,7.025527695404844e-23,False,,"Path 1: No (Pralsetinib, inhibits, CSF1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CSF1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
44,FGR,6.959589021147954e-23,False,,"Path 1: No (Pralsetinib, inhibits, FGR) edge in KG; GNN predicts link (score=0.0000). Path 2: No (FGR, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
45,PARP1,6.702706249237957e-23,False,,"Path 1: No (Pralsetinib, inhibits, PARP1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PARP1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
46,CNP,6.609774648070576e-23,False,,"Path 1: No (Pralsetinib, inhibits, CNP) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CNP, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
47,POLA1,6.407219780070065e-23,False,,"Path 1: No (Pralsetinib, inhibits, POLA1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (POLA1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
48,ANXA4,6.160846528683782e-23,False,,"Path 1: No (Pralsetinib, inhibits, ANXA4) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ANXA4, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
49,IFIT1,6.080087997917048e-23,False,,"Path 1: No (Pralsetinib, inhibits, IFIT1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (IFIT1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
50,UCHL1,5.750344139534665e-23,False,,"Path 1: No (Pralsetinib, inhibits, UCHL1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (UCHL1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
51,CLTA,5.488586838319126e-23,False,,"Path 1: No (Pralsetinib, inhibits, CLTA) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CLTA, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
52,H2AC11,5.179667014568405e-23,False,,"Path 1: No (Pralsetinib, inhibits, H2AC11) edge in KG; GNN predicts link (score=0.0000). Path 2: No (H2AC11, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
53,TPM1,4.613926265602656e-23,False,,"Path 1: No (Pralsetinib, inhibits, TPM1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (TPM1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
54,POLR2M,4.3341015253026594e-23,False,,"Path 1: No (Pralsetinib, inhibits, POLR2M) edge in KG; GNN predicts link (score=0.0000). Path 2: No (POLR2M, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
55,FBP1,3.627581921368616e-23,False,,"Path 1: No (Pralsetinib, inhibits, FBP1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (FBP1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
56,TRAPPC2,3.596346184965485e-23,False,,"Path 1: No (Pralsetinib, inhibits, TRAPPC2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (TRAPPC2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
57,ACADVL,2.976384817173361e-23,False,,"Path 1: No (Pralsetinib, inhibits, ACADVL) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ACADVL, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
58,TRAPPC2B,2.956299471893348e-23,False,,"Path 1: No (Pralsetinib, inhibits, TRAPPC2B) edge in KG; GNN predicts link (score=0.0000). Path 2: No (TRAPPC2B, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
59,FGF2,2.682873971256504e-23,False,,"Path 1: No (Pralsetinib, inhibits, FGF2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (FGF2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
60,RAB34,2.037910919250848e-23,False,,"Path 1: No (Pralsetinib, inhibits, RAB34) edge in KG; GNN predicts link (score=0.0000). Path 2: No (RAB34, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
61,ROS1,1.9726509809168105e-23,False,,"Path 1: No (Pralsetinib, inhibits, ROS1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ROS1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
62,RPSA,1.442990994261879e-23,False,,"Path 1: No (Pralsetinib, inhibits, RPSA) edge in KG; GNN predicts link (score=0.0000). Path 2: No (RPSA, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
63,TUBA3C,1.372077289820122e-23,False,,"Path 1: No (Pralsetinib, inhibits, TUBA3C) edge in KG; GNN predicts link (score=0.0000). Path 2: No (TUBA3C, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
64,VIM,1.0508651198998854e-23,False,,"Path 1: No (Pralsetinib, inhibits, VIM) edge in KG; GNN predicts link (score=0.0000). Path 2: No (VIM, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
65,RARA,8.87638754556985e-24,False,,"Path 1: No (Pralsetinib, inhibits, RARA) edge in KG; GNN predicts link (score=0.0000). Path 2: No (RARA, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
66,ITGA5,7.624592295589846e-24,False,,"Path 1: No (Pralsetinib, inhibits, ITGA5) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ITGA5, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
67,CEBPA,6.740960007798296e-24,False,,"Path 1: No (Pralsetinib, inhibits, CEBPA) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CEBPA, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
68,SAG,5.572613619816191e-24,False,,"Path 1: No (Pralsetinib, inhibits, SAG) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SAG, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
69,FCGR3A,5.515722943483914e-24,False,,"Path 1: No (Pralsetinib, inhibits, FCGR3A) edge in KG; GNN predicts link (score=0.0000). Path 2: No (FCGR3A, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
70,SNRNP70,3.981534422096512e-24,False,,"Path 1: No (Pralsetinib, inhibits, SNRNP70) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SNRNP70, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
71,BLTP3B,3.106078480372353e-24,False,,"Path 1: No (Pralsetinib, inhibits, BLTP3B) edge in KG; GNN predicts link (score=0.0000). Path 2: No (BLTP3B, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
72,CYP2C8,2.9900281665291585e-24,False,,"Path 1: No (Pralsetinib, inhibits, CYP2C8) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CYP2C8, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
73,MMP2,2.8067933304014582e-24,False,,"Path 1: No (Pralsetinib, inhibits, MMP2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (MMP2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
74,CHRM2,1.9664663508629228e-24,False,,"Path 1: No (Pralsetinib, inhibits, CHRM2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CHRM2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
75,PRIM2,1.6021569741964708e-24,False,,"Path 1: No (Pralsetinib, inhibits, PRIM2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PRIM2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
76,CHGA,1.5920071939670578e-24,False,,"Path 1: No (Pralsetinib, inhibits, CHGA) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CHGA, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
77,LAMB1,1.3796080715657241e-24,False,,"Path 1: No (Pralsetinib, inhibits, LAMB1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (LAMB1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
78,ARHGAP10,1.0947497084371243e-24,False,,"Path 1: No (Pralsetinib, inhibits, ARHGAP10) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ARHGAP10, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
79,HNRNPC,9.327847316816725e-25,False,,"Path 1: No (Pralsetinib, inhibits, HNRNPC) edge in KG; GNN predicts link (score=0.0000). Path 2: No (HNRNPC, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
80,KIT,8.526408024461964e-25,False,,"Path 1: No (Pralsetinib, inhibits, KIT) edge in KG; GNN predicts link (score=0.0000). Path 2: No (KIT, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
81,PFN1,6.183348647954553e-25,False,,"Path 1: No (Pralsetinib, inhibits, PFN1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PFN1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
82,CLU,4.603794708060154e-25,False,,"Path 1: No (Pralsetinib, inhibits, CLU) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CLU, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
83,CAPN1,3.951813988884697e-25,False,,"Path 1: No (Pralsetinib, inhibits, CAPN1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CAPN1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
84,PPM1F,3.91352958307819e-25,False,,"Path 1: No (Pralsetinib, inhibits, PPM1F) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PPM1F, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
85,FAM170A,3.774143038025328e-25,False,,"Path 1: No (Pralsetinib, inhibits, FAM170A) edge in KG; GNN predicts link (score=0.0000). Path 2: No (FAM170A, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
86,GP1BA,2.4576811125550565e-25,False,,"Path 1: No (Pralsetinib, inhibits, GP1BA) edge in KG; GNN predicts link (score=0.0000). Path 2: No (GP1BA, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
87,MCF2,2.410126851555104e-25,False,,"Path 1: No (Pralsetinib, inhibits, MCF2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (MCF2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
88,H1-0,1.45708907755611e-25,False,,"Path 1: No (Pralsetinib, inhibits, H1-0) edge in KG; GNN predicts link (score=0.0000). Path 2: No (H1-0, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
89,SH3PXD2B,1.2747315533626289e-25,False,,"Path 1: No (Pralsetinib, inhibits, SH3PXD2B) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SH3PXD2B, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
90,MYL2,1.2707648156045318e-25,False,,"Path 1: No (Pralsetinib, inhibits, MYL2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (MYL2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
91,CENPA,9.842248352190824e-26,False,,"Path 1: No (Pralsetinib, inhibits, CENPA) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CENPA, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
92,NEFM,9.253734697587826e-26,False,,"Path 1: No (Pralsetinib, inhibits, NEFM) edge in KG; GNN predicts link (score=0.0000). Path 2: No (NEFM, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
93,MAP2,6.766252885223848e-26,False,,"Path 1: No (Pralsetinib, inhibits, MAP2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (MAP2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
94,H2BC11,5.955795680127247e-26,False,,"Path 1: No (Pralsetinib, inhibits, H2BC11) edge in KG; GNN predicts link (score=0.0000). Path 2: No (H2BC11, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
95,CCDC66,4.261971725215365e-26,False,,"Path 1: No (Pralsetinib, inhibits, CCDC66) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CCDC66, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
96,PTMA,3.8887049315777417e-26,False,,"Path 1: No (Pralsetinib, inhibits, PTMA) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PTMA, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
97,RALA,3.666377119541634e-26,False,,"Path 1: No (Pralsetinib, inhibits, RALA) edge in KG; GNN predicts link (score=0.0000). Path 2: No (RALA, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
98,MYL1,2.5783789264656508e-26,False,,"Path 1: No (Pralsetinib, inhibits, MYL1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (MYL1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
99,FNTB,2.41442296955601e-26,False,,"Path 1: No (Pralsetinib, inhibits, FNTB) edge in KG; GNN predicts link (score=0.0000). Path 2: No (FNTB, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
100,ERG,1.993207453650944e-26,False,,"Path 1: No (Pralsetinib, inhibits, ERG) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ERG, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
